Reduction of advanced tau-mediated memory deficits by the MAP kinase p38γ

Research output: Contribution to journalMeeting Abstractpeer-review


BACKGROUND: Hyperphosphorylation of the neuronal tau protein contributes to Alzheimer's disease (AD) by promoting tau pathology and neuronal and cognitive deficits. In contrast, we have previously shown that site-specific tau phosphorylation can inhibit toxic signals induced by amyloid-β (Aβ) in mouse models. The post-synaptic mitogen-activated protein (MAP) kinase p38γ mediates this site-specific phosphorylation on tau at Threonine-205 (T205). 

Original languageEnglish
Pages (from-to)e054596
Number of pages1
JournalAlzheimer's & dementia : the journal of the Alzheimer's Association
Issue numberS3
Publication statusPublished - Dec 2021
Externally publishedYes
EventAlzheimer's Association International Conference 2021 - Denver, United States
Duration: 26 Jul 202130 Jul 2021


  • Hyperphosphorylation
  • Tau protein
  • MAP kinase
  • p38 MAP kinase
  • memory deficits


Dive into the research topics of 'Reduction of advanced tau-mediated memory deficits by the MAP kinase p38γ'. Together they form a unique fingerprint.

Cite this